• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070250-18
Device Problems Deflation Problem (1149); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/01/2019
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Exemption number (b)(4).The customer reported the device was discarded.Investigation is not yet complete.A follow-up will be submitted with all relevant information.
 
Event Description
It was reported that the procedure was to treat an 80% stenosed, moderately calcified lesion in the mid right coronary artery (rca).Reportedly, the device was not air aspirated outside the anatomy prior to use.Pre-dilatation was performed and the 2.5x18 mm xience xpedition stent delivery system was introduced to the artery and taken to the lesion for deployment.While deploying the stent, the physician noted difficulty deflating the stent balloon.The balloon was inflated again to 14 atmospheres (atm) and then held negative for 15 seconds, partially deflating the balloon in order to be removed.The stent was successfully deployed.There were no reported adverse patient effects and there was no reported clinically significant delay in the procedure.The physician expressed concern about the stent delivery system.No additional information was provided.
 
Event Description
Additional information received indicates that the device was not prepped.No additional information was provided.
 
Manufacturer Narrative
Exemption number e2019001.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.It was reported xience xpedition device was not prepped prior to use.It should be noted that the xience xpedition everolimus eluting coronary stent system instruction for use lists system preparation to be performed prior to delivery procedure.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely the device had difficulty deflating due to the reported instruction for use deviation related to not prepping the device prior to use.The device preparation process removes the air from the inflation lumen, it is likely air in the inflation lumen caused and/or contributed to the reported deflation issues.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key8822903
MDR Text Key152085856
Report Number2024168-2019-10305
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/18/2022
Device Catalogue Number1070250-18
Device Lot Number9011441
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/03/2019
Initial Date FDA Received07/24/2019
Supplement Dates Manufacturer Received08/22/2019
Supplement Dates FDA Received09/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-